PD Dr. Arnd Kleyer

Lehrstuhl für Innere Medizin III Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

Anatomical pattern of entheseal and synovial fibroblast activation in patients with psoriasis and its risk of developing psoriatic arthritis (2024) Corte G, Atzinger A, Temiz SA, Noversa de Sousa R, Mutlu MY, Schönau V, Raimondo MG, et al. Journal article AB0208 Reduced Hand Function Indicates Higher Disease Activity In Patients With Rheumatoid And Psoriatic Arthritis (2024) Coppers B, Heinrich S, Bayat S, Tascilar K, Kleyer A, Simon D, Minopoulou I, et al. Journal article CHARACTERIZATION OF PHYSICAL ACTIVITY BEHAVIOUR IN VASCULITIS PATIENTS (2024) Nain K, Schönau V, Guilhon de Araujo E, Reis P, Ebner I, Coppers B, Tascilar K, et al. Journal article AB0929 THE IMPACT OF KINESIOPHOBIA ON GAIT KINEMATICS IN PATIENTS WITH SPONDYLOARTHROPATHIES (2024) Schweiger I, Koschinsky J, Godonou ET, Tascilar K, Coppers B, Kleyer A, Morf H, et al. Journal article Metabolic and molecular imaging in inflammatory arthritis (2024) Noversa de Sousa R, Tascilar K, Corte G, Atzinger A, Minopoulou I, Ohrndorf S, Waldner M, et al. Journal article, Review article Classification of rheumatoid arthritis from hand motion capture data using machine learning (2024) Fleischmann S, Holzwarth Correa V, Coppers B, Sadeghi M, Richer R, Kleyer A, Simon D, et al. Conference contribution, Conference Contribution Baricitinib as monotherapy for treatment of rheumatoid arthritis: analysis of real-world data (2024) Edwards CJ, Takeuchi T, Finckh A, Kleyer A, Haladyj E, Gerwien JG, Treuer T, et al. Journal article, Review article Enhancing student understanding of rheumatic disease pathologies through augmented reality: findings from a multicentre trial. (2024) Pfeil A, Klemm P, Hueber AJ, Hoffmann T, Weise T, Oelzner P, Knop S, et al. Journal article Comparison and Improvement of CyberGlove III calibration methods (2024) Heinrich S, Michaelis J, Reiher I, Coppers B, Lohmayer M, Fleischmann ME, Kleyer A, et al. Journal article, Original article Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study. (2024) Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, et al. Journal article